Catalent appoints trio of managers

New general managers will be based in Japan, US and Argentina

Catalent Pharma Solutions has appointed three new members of staff to strengthen its global pharmaceutical manufacturing network.

Jochen Rohe has joined as country general manager, softgel manufacturing, Catalent Japan after a long global career at BASF.

David Bricker becomes general manager, sterile technologies at Catalent’s Woodstock, US blow/fill/seal facility. He has led an extensive sterile manufacturing career at Anheuser Busch, Boehringer Ingelheim and AstraZeneca.

Sergio Alter has been appointed as general manager of Catalent’s recently expanded softgel manufacturing facility in Buenos Aires, Argentina after a career at Sandoz and Janssen-Cilag.

You may also like

Manufacturing

Catalent expands integrated development, manufacturing and supply for modalities

Originally launched in 2019 for early-phase protein therapy development, OneBio Suite offers customers an integrated service
Manufacturing

Catalent adds cryogenic capabilities to support gene development

The facility in Shiga will include the storage, kitting, and distribution of advanced therapies at ultra-low temperatures for clinical trials
Manufacturing

Catalent begins $20 million construction project

The project creates space in the original building to accommodate the installation of a new, fully automatic bottle filling line
Manufacturing

Catalent and Bhami announce licensing agreement

Catalent will be authorised to collaborate with its customers to evaluate BRL’s formulation technology
Manufacturing

Catalent expands platform process for viral vectors

Processes can now benefit through increased consistency and efficiency, potentially reducing the time
Manufacturing

Catalent completes $2.2 million expansion to clinical supply facility

The site in Singapore serves the Asia-Pacific region with a wide range of clinical supply services
Manufacturing

Catalent opens Belgium cell therapy manufacturing centre

The newly completed facility is the latest addition to Catalent’s Gosselies campus, which already includes a 67,000 sqft clinical manufacturing facility offering customers advanced clinical and commercial supply solutions
Subscribe now